跳至主要内容
临床试验/JPRN-UMIN000012512
JPRN-UMIN000012512尚未招募2 期

Evaluation of the effect onset with Propiverine hydrochloride(BUP-4) in Female Patients diagnosed as overactive bladder. - Evaluation of the effect onset with Propiverine hydrochloride(BUP-4) in Female Patients diagnosed as overactive bladder.

Saitama Continence Conference0 个研究点目标入组 30 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Patients with bladder stone, urethral calculus, interstitial cystitis 2) Patients with endometriosis required for surgery and pelvic organ prolapse 3) Patients with history of treatment OAB within 2 months 4) Patients with treatment for cancer 5) Patients with lower urinary tract symptom 6) Patients with symptomatic urinary tract infection 7) Patients with polyuria (>=3000mL /day) 8) Other severe complications, such as uncontrolled diabetes mellitus, uncontrolled hypertension) 9) Patients with angle-closure glaucoma 10) Patients with severe heart dysfunction, renal dysfunction, liver dysfunction 11) Women who are capable of pregnancy, intend to get pregnant 12) Pregnant or lactating women 13) Judged ineligible based on physicians' decision

研究者

发起方
Saitama Continence Conference

相似试验